Ignite Creation Date:
2025-12-24 @ 3:17 PM
Ignite Modification Date:
2026-03-26 @ 8:22 PM
Study NCT ID:
NCT00912392
Status:
COMPLETED
Last Update Posted:
2014-09-03
First Post:
2009-06-01
Is NOT Gene Therapy:
True
Has Adverse Events:
False
Brief Title:
Etoposide-Carboplatin Alone or With Endostar for Extensive Disease Small Cell Lung Cancer (ED-SCLC)
Sponsor:
Shandong Simcere-Medgenn Bio-pharmaceutical Co., Ltd
Organization:
Organization Data
Organization:
Class:
INDUSTRY
Study ID:
SIM-69
Study Type:
None
Study Domain:
None
Study Link:
None
Lead Sponsor:
Lead Sponsor Class:
INDUSTRY
Responsible Party:
Responsible Party Title:
Responsible Party Type:
SPONSOR
Responsible Party Affiliation:
Old Name:
None
Old Organization:
None